Follow this preprint

The use of angiotensin-converting enzyme inhibitors in hospitalized patients with COVID-19 is associated with a lower risk of mortality

Mykola Khalangot, Vitaliy Gurianov, Tamara Zakharchenko, Victor Kravchenko, Olena Kovzun, Volodymyr Shupachynskiy, Mykola Tronko
doi: https://doi.org/10.1101/2025.03.12.25323615
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2025.03.12.25323615
History 
  • March 14, 2025.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Mykola Khalangot1,5 (nikhalangot{at}ukr.net),
  2. Vitaliy Gurianov2,
  3. Tamara Zakharchenko3,
  4. Victor Kravchenko3,
  5. Olena Kovzun3,
  6. Volodymyr Shupachynskiy4 and
  7. Mykola Tronko3
  1. 1 Shupyk National Healthcare University of Ukraine;
  2. 2 Bohomolets National Medical University, Kyiv, Ukraine;
  3. 3 Komisarenko Institute of Endocrinology and Metabolism;
  4. 4 Kyiv Municipal Clinic #8
  1. ↵* Corresponding author; email: nikhalangot{at}ukr.net
Back to top
Posted March 14, 2025.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
The use of angiotensin-converting enzyme inhibitors in hospitalized patients with COVID-19 is associated with a lower risk of mortality
Mykola Khalangot, Vitaliy Gurianov, Tamara Zakharchenko, Victor Kravchenko, Olena Kovzun, Volodymyr Shupachynskiy, Mykola Tronko
medRxiv 2025.03.12.25323615; doi: https://doi.org/10.1101/2025.03.12.25323615
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.